Background
Tuberculosis (TB) is an infectious disease and a significant global public health problem [
1,
2]. There were an estimated 10.1 million incident TB cases worldwide in 2017 [
3], of which about 6.4 million were notified. Of these, there were an estimated 558,000 cases of multidrug-resistant TB (MDR-TB) and rifampicin resistant TB (RR-TB) [
3]. China is one of the 30 high TB burden countries. Although the TB incidence rate and the case fatality ratio have fallen, TB continues to be a public health problem in China [
3]. TB is also a public health problem in Beijing, the capital of the People’s Republic of China [
4]. There is a need for more studies to clarify the association between drug resistance and genotype diversity in Beijing, in particular to, investigate the relationship between drug resistance and Beijing genotype family strains.
Molecular biology tools have been used extensively to determine the genotypic diversity of
M.tb strains, and have played an important role in TB control and understanding TB epidemiology over the last few decades [
5‐
7]. Spoligotyping and Variable number of tandem repeat (VNTR) are considered to be powerful tools for differentiating the
M.tb complex into various genotypes [
8,
9].While there are many different
M.tb genotypes,
M.tb Beijing genotype strains have attracted global attention because of their wide geographical distribution [
10]. Beijing genotype strains were first described by van Soolingen et al. in 1995, and were named after Beijing as they were isolated there [
11]. Later, the Beijing genotype was also detected in other regions of the world, especially in East Asia [
12‐
14]. Beijing genotype strains are generally considered to be correlated with community outbreaks of TB [
15], escaping from the protective effect of the BCG vaccine [
16], efficient dissemination or increased virulence [
17], and an increased risk on the occurrence of drug resistance [
18,
19].
It is very important to have a clearer understanding of the association between the prevalence of Beijing genotype
M.tb and resistance to anti-TB drugs. Studies to date have not come to consistent conclusions. While some studies have suggested that development of drug resistance in
M.tb is associated with its genotype [
8,
20], drug resistance more likely occurring among Beijing genotype strains [
19,
21,
22], and that Beijing genotype strains are more probably develop MDR-TB [
23] and be clustered [
24], different results have been obtained in different cities and regions [
7,
25]. It would appear that the conclusion drawn from a particular study depends upon the project setting considered, the types of drugs considered and the geographical distribution of strains [
26].
Beijing is confronting public health issues in the prevention and control of TB [
4,
27]. The association between the prevalence of Beijing genotype strains and their drug resistance status in Beijing is unclear. Studies to date have been hindered by many problems, including the fact that the
M.tb strains chosen were not sufficiently representative, or the number of strains included in was relatively low [
21,
22,
28]. It is thus necessary to clarify the situation, particularly considering the high prevalence of tuberculosis and the inconsistent conclusions obtained from different regions and laboratories.
To clarify if there is an association between the Beijing genotype and resistance to anti-TB drugs, we investigated drug susceptibility patterns in Beijing genotype and non-Beijing genotype strains of M.tb strains in Beijing, comparing differences in patterns of drug resistance, and analyzing the relationship between genotype patterns and DST results. This study provides important insight into the association between Beijing genotype family strains and resistance to first-line anti-TB drugs in Beijing.
Discussion
As far as we know, this is a large-scale study to assess the prevalence of the Beijing genotype M.tb strains in Beijing and their association with drug resistance. The Beijing genotype family of M.tb is one of the most successful lineages in the present global tuberculosis epidemic. In order to understand how drug-resistant TB develops and to find better ways to control TB, it is essential to understand the molecular epidemiology of M.tb. Prior to this study, however, the prevalence of Beijing strains and their drug resistance status in Beijing, the city after which they were named, was unclear.
To examine these problems, we made use of strain collection containing 1189 isolates from a previous project in Beijing [
4]. We described the detailed population structure of both Beijing and non-Beijing genotype strains, and investigated the association between the prevalence of Beijing genotype strains of
M.tb and drug resistance in Beijing.
It has often been found that the prevalence of TB is higher in men than in women [
32]. Consistent with results of previous studies [
21,
34], we found that men are more probably be infected by
M.tb; in the pan-susceptible group, men were more probably be infected by Beijing genotype
M.tb strains (Table
3). As this the result may be affected by the gender ratio in the local population [
31], we examined the overall gender ratio in Beijing. As the gender ratio in Beijing was 1.07 to1 (male: female) in 2010 [
35], it is likely that the reason for the difference observed is due to differences in susceptibility to
M.tb among local populations.
With the exception of gender, age was an association factor for infection by the Beijing genotype. A previous study demonstrated that younger patients (aged under 25 years) were likely to be infected with the Beijing genotype [
21]. However, we did not observe such a tendency. Instead, we observed that individuals in the middle-aged group were more probably be infected with Beijing genotype strains of
M.tb, and elderly people were more probably be infected with non-Beijing genotype strains. These results may reflect the possibility that middle-aged and older population groups in Beijing may have different social networks and work situations, suggesting that the population of different region could confront different risks. Further research is required to clarify this hypothesis. Except for age, we found that the non-resident population was more probably be infected by non-Beijing genotype strains of
M.tb. Non-residents tend to live in areas of Beijing where the population density is high and work in crowded public environments. Non-Beijing genotype
M.tb strains probably likely spread more readily in these districts.
Research on molecular epidemiology has greatly improved our understanding of TB prevalence. A study from Shanghai has also suggested that Beijing genotype strains are associated with recent transmission of TB and are more probably be clustered [
36] [
24]. Consistent with this finding, we found that Beijing genotype strains in the study population were significantly associated with clustering, suggesting recent transmission mechanisms are likely significantly different from those of non-Beijing genotype strains. Moreover, VNTR method separated the
M.tb Beijing genotype strains into much more branches and much smaller clusters, suggesting that it possessed a higher discriminatory power than the spoligotyping method [
27].
Evidence has shown that drug resistance in
M.tb is more probably occur among Beijing genotype strains [
19,
21,
22]. However, the nature of the association found between drug resistance and the Beijing genotype has varied between studies, [
7,
25]. When we analyzed the percentage of drug resistant strains in different genotypes, results indicated that there was an association between the occurrence of INH resistance and the prevalence of non-Beijing genotype strains. In regard to MDR-TB, some studies have suggested that Beijing genotype strains are more probably develop MDR-TB [
23]. Here, however, our data did not support this hypothesis. Our data also revealed a relatively high prevalence of MDR-TB in Beijing, but did not show a significant difference in the percentage of MDR-TB between Beijing and non-Beijing genotypes, suggesting that there is no significant association between the occurrence of MDR-TB and the prevalence of Beijing genotype strains.
According to previous reports and this study, the association between the occurrence of drug-resistance and the prevalence of Beijing genotype strains is variable [
19‐
21]. Possible explanations for the variability include: 1) the number and percentage of Beijing genotype strains included in a study influences the results [
36,
37]; 2) variation in the frequency of strains with different drug resistance patterns is influenced by differences in treatment regimens and tuberculosis control programs in different regions [
38], as well as characteristics of the host population, socioeconomic factors, or any combination of these factors [
39]; and 3) the uneven geographical distribution of the Beijing genotype will also influence the association [
40,
41]. Further detailed studies on the association are needed.
While our results are important, this study has some limitations. The association between genotypic diversity and drug resistance is a very complex problem, and research that bears additional factors and underlying reasons in mind is required [
37]. Although no selection bias was detected in the demographic characteristics of our study population, there is a higher incidence of serious TB cases in this region, which may have led to an overestimation of drug-resistant TB. In addition, we used traditional Spoligotyping and VNTR methods; better methods may be available used in the future to identify and analyze the Beijing genotype. With developments in science and technology, whole genome sequencing (WGS) can provide greater precision than traditional genotyping for studying the recent transmission of
M.tb [
38]. Nevertheless, spoligotyping and VNTR are still valuable tools for identifying genotypes and performing cluster analysis [
39‐
42]. Each technique has its own advantages and disadvantages and we will combine classical genotyping, WGS, and epidemiological investigations in future studies.